-
Spurs win in Wembanyama return to take 3-1 lead on Trail Blazers
-
Toulouse fall to first home defeat for a year
-
Global military spending surges on insecurity: report
-
Marseille see Champions League chance slip further away
-
Nelly Korda wins LPGA Chevron Championship
-
Syrian court begins proceedings against Assad and allies
-
Colombia road bombing death toll rises to 20
-
Raptors top Cavs to pull level in NBA playoff series
-
Iran minister heads to Russia as talks remain stalled
-
Rinku stars as Kolkata edge Lucknow in Super Over
-
T'Wolves Edwards to miss several weeks - report
-
Michael Jackson biopic debuts atop N. America box office
-
King Charles state visit to US to go on as planned after shooting
-
Inter pegged back by Torino as Serie A title charge hits bump in road
-
Mali junta in crisis after minister killed, key city 'captured'
-
Dortmund down Freiburg to seal Champions League spot
-
McFarlane hails Chelsea 'character' after FA Cup semi-final win
-
Gunman sought to kill Trump, cabinet at gala dinner
-
Arsenal punish Lyon errors in Champions League semi
-
Suspect in US press gala shooting - what we know
-
Key US senator lifts block on Fed chair nominee
-
Attacks in Mali: What we know
-
Vollering wins women's Lige-Bastogne-Liege for 3rd time
-
Sinner motors on in Madrid as Gauff overcomes stomach bug
-
Fernandez sends Chelsea into FA Cup final to lift gloom after Rosenior sacking
-
Colombia road bombing death toll rises to 19
-
Stuttgart stumble against Bremen in top-four race
-
Two former Israel PMs unite to challenge Netanyahu in elections
-
Trump says shooting proves need for his White House ballroom
-
Pogacar cracks teen Seixas to win 4th Liege-Bastogne-Liege
-
Iran minister returns to Pakistan despite US talks cancellation
-
Rabada's 3-25 helps Gujarat thrash Chennai in IPL
-
Pogacar beats teen Seixas to win 4th Liege-Bastogne-Liege
-
Gunman planned to target top Trump officials: attorney general
-
Alex Marquez wins Spanish MotoGP to end Bezzecchi streak
-
History-maker Sawe shatters marathon glass ceiling
-
Gauff overcomes stomach bug to beat Cirstea in Madrid
-
Mali defence minister killed, fresh fighting between army and rebels
-
Sawe makes history with first sub-two-hour marathon in London
-
Assefa wins London Marathon in women's-only world record time
-
Superstar galloper Ka Ying Rising storms to 20th straight win
-
Austria's Wiesberger wins first DP World Tour title in 1,792 days
-
Cummins hails teen wonder Sooryavanshi as 'my new favourite player'
-
New fighting in Mali's Kidal between army and rebels
-
Chernobyl refugee town welcomes Ukraine's conflict displaced
-
World leaders react to Washington gala shooting
-
Zelensky accuses Russia of 'nuclear terrorism' on Chernobyl anniversary
-
Coach says 'glimmer of hope' for imperilled Moana Pasifika
-
'I've studied assassinations': Trump muses on reasons for latest shooting
-
What we know about the Trump press gala shooting
PolyPid Ltd. to Present at the Q1 Investor Summit Virtual Conference on March 11th, 2025
NEW YORK, NY / ACCESS Newswire / February 27, 2025 / The Investor Summit Group (ISG), today announced that Ori Warshavsky, Chief Operating Officer - US Operations and Jonny Missulawin, Chief Financial Officer of PolyPid Ltd. (Nasdaq:PYPD), a late-stage biopharma company aiming to improve surgical outcomes will be presenting at this year's Investor Summit Virtual Conference on March 11th, 2025.
The PolyPid management team will participate in one-on-one investor meetings during this event. Investors interested in meeting with PolyPid at the conference should contact their ISG representative.
About PolyPid Ltd.
PolyPid Ltd. is a late-stage biopharma company aiming to improve surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid's proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with Active Pharmaceutical Ingredients (APIs), enabling precise delivery of drugs at optimal release rates over durations ranging from several days to months. PolyPid's lead product candidate D-PLEX100 is in Phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the Company is currently in preclinical stages to test the efficacy of OncoPLEX for the treatment of solid tumors, beginning with glioblastoma.
For additional PolyPid information, please visit http://www.polypid.com and follow on Twitter and LinkedIn.
Event: Q1 Investor Summit Virtual Conference
Presentation Time: 10:00 AM ET
Location: https://www.webcaster4.com/Webcast/Page/3082/52088
Conference Overview and Structure
The Investor Summit is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various subject matter experts, and see what your peers are doing in this market.
This quarter's event is focused on MicroCap companies who are undervalued, have a catalyst, and are undervalued.
Registration for Investors
To request free registration, please go to our website (https://investorsummitgroup.com/), and click the "Registration" button.
Sponsors:
ACCESS Newswire
PCG Advisory
QuoteMedia
AGP
MZ Group
News Compliments of ACCESS Newswire
For More Information please visit: https://investorsummitgroup.com/
Or contact [email protected]
SOURCE: PolyPid Ltd.
View the original press release on ACCESS Newswire
P.Stevenson--AMWN